Home Search
viaskin - search results
If you're not happy with the results, please do another search
FDA Agreement Clears Regulatory Path for Viaskin Peanut Patch
DBV Technologies will submit its Viaskin Peanut FDA application in late 2026 after agreeing to include additional safety data.
Viaskin Peanut Patch Shows 83% Success Rate in Increasing Tolerance in Young Children
DBV Technologies' VITESSE trial showed Viaskin Peanut patch effectively increases peanut tolerance in children, supporting their upcoming submission for approval to the FDA.
DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3...
Many of the children treated with the patch were able to tolerate significantly more peanut protein than they could before the study.
Optimism Grows for Toddlers with Peanut Allergies as Viaskin Patch Safety Study Begins
DBV Technologies anticipates their submission to the FDA will occur in the second half of 2026
DBV Confirms Alignment with FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in...
Toddlers study on-track to initiate in 2Q 2025.
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and...
Company to pursue an Accelerated Approval pathway for toddlers ages 1–3 years-old.
Viaskin Patch Improves Treatment for Pediatric Milk Allergies
The patch releases small doses of a milk allergen protein through the skin without ingestion.
Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler Study
81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch
Are Viaskin therapies finally on the horizon?
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved